Exhibit
        31.2
 
 **CERTIFICATION
        OF PRINCIPAL EXECUTIVE AND OFFICERS**
 **PURSUANT
        TO RULES 13A-14 AND 15D-14**
 **OF
        THE SECURITIES AND EXCHANGE ACT OF 1934**
 
 
 I,
        Haijing (Carrie) Wang, Chief Financial Officer, certify that:
 
 1.  I
        have
        reviewed this quarterly report on Form 10-QSB of AOB Biotech, Inc.;
 
 2.  Based
        on
        my knowledge, this quarterly report does not contain any untrue statements
        of a
        material fact or omit to state a material fact necessary to make the statements
        made, in light of the circumstances under which such statements were made,
        not
        misleading with respect to the period covered by this quarterly
        report;
 
 3.  Based
        on
        my knowledge, the financial statements, and other financial information included
        in this quarterly report, fairly present in all material respects the financial
        condition, results of operations and cash flows of the registrant as of,
        and
        for, the periods presented in this quarterly report;
 
 4.  The
        registrant's other certifying officers and I are responsible for establishing
        and maintaining disclosure controls and procedures (as defined in Exchange
        Act
        Rules 13a-14 and 15d-14) for the registrant and we have:
 
 a)
            designed
                such disclosure controls and procedures to ensure that material
                information relating to the registrant, including its consolidated
                subsidiaries, is made known to us by others within those entities,
                particularly during the period in which this quarterly report is
                being
                prepared; 
 b)
            evaluated
                the effectiveness of the registrant's disclosure controls and procedures
                as of a date within 90 days prior to the filing date of this quarterly
                report (the "Evaluation Date"); and 
 c)
            presented
                in this quarterly report our conclusions about the effectiveness
                of the
                disclosure controls and procedures based on our evaluation as of
                the
                Evaluation Date; 
 5.  The
        registrant's other certifying officers and I have disclosed, based on our
        most
        recent evaluation, to the registrant's auditors and the registrant's board
        of
        directors (or persons performing the equivalent functions):
 
 a)
            all
                significant deficiencies in the design or operation of internal controls
                which could adversely affect the registrant's ability to record,
                process,
                summarize and report financial data and have identified for the
                registrant's auditors any material weaknesses in internal controls;
                and 
 b)
            any
                fraud, whether or not material, that involves management or other
                employees who have a significant role in the registrant's internal
                controls; and 
 6.  The
        registrant's other certifying officers and I have indicated in this quarterly
        report whether or not there were significant changes in internal controls
        or in
        other factors that could significantly affect internal controls subsequent
        to
        the date or our most recent evaluation, including any corrective actions
        with
        regard to significant deficiencies and material weaknesses.
 
 April
                  13, 2007
              ***/s/
                  Haijing (Carrie) Wang****Haijing
                  (Carrie) Wang**Chief
                  Financial Officer*